Cohort Project of Patients With Inflammatory Rheumatism

Sponsor
Centre Hospitalier Universitaire de Nice
Study ID
NCT06059430
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • no intervention — OTHER
    no intervention

Study Details

Chronic inflammatory rheumatism (CIR) is a group of inflammatory diseases that affect the joints and spine and are related to an abnormal immune response. CIR includes many different forms of arthritis that manifest as painful and swollen joints, stiffness, especially in the morning and persisting even after exercise, and limited joint mobility. CIR can also affect bones, cartilage, ligaments, tendons and muscles. Some may affect other organs. These symptoms can lead to a reduced quality of life, limited physical activity and progressive structural and functional deterioration of the joints. Current treatment for CIR is aimed at reducing inflammation and relieving pain. Anti-inflammatory medications such as corticosteroids and non-steroidal anti-inflammatory drugs can be used to relieve pain and inflammation. Biotherapies can also be used to modify the progression of the disease. On the other hand, regular exercise can help strengthen the muscles that support the affected joints and improve mobility. Physical therapies, such as physical and occupational therapy, can also help improve mobility and relieve pain. Although there is no definitive cure for CIR early and appropriate treatment can help reduce symptoms and improve quality of life, as well as avoid the risk of developing complications such as lung, cardiovascular, kidney, ophthalmic, liver and other diseases. It is in this context, in order to better understand CIR to improve the global management of patients, and to analyze the evolution of CIR over time in relation to the different treatments proposed, that the interest in creating a database of patients with CIR arises.

Key Dates

First listed
Sep 28, 2023
Start date
Sep 20, 2023
Status verified
Sep 2023
Primary completion
Sep 20, 2043
Completion
Dec 20, 2043

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: patient already on treatment
    Patients already on biologic or synthetic TRT will be followed for 10 years
  • Arm: Naive patients
    Patients who are naive to biological or synthetic treatments

Primary Outcome Measure

compare rheumatoid arthritis activity [ Time Frame: evrey year during 10 years ]

Central Contacts

Find similar trials

Nationwide
Psoriatic arthritis trialsRheumatoid arthritis trialsRheumatology trialsAutoimmune disease trialsMusculoskeletal disorders trials

Related Studies